Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00274963
Recruitment Status : Completed
First Posted : January 11, 2006
Last Update Posted : October 3, 2016
Information provided by:
German CLL Study Group